Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inducing Systemic Immunity and Regressions in Metastatic Melanoma

NCT02350972 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02350972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02350972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inducing Systemic Immunity and Regressions in Metastatic Melanoma
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
July 31, 1978
Completion date
May 31, 2002
Enrollment
88 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant melanoma